Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease
- 31 May 1994
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 19 (5) , 865-872
- https://doi.org/10.1016/s0741-5214(94)70012-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Regulation of fibrinolysis by vascular endotheliumCoronary Artery Disease, 1991
- Elastin degradation in abdominal aortic aneurysmsAtherosclerosis, 1987
- Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.Journal of Clinical Investigation, 1986
- Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor.Journal of Clinical Investigation, 1985
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983
- Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages.The Journal of Experimental Medicine, 1980
- Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells.Journal of Clinical Investigation, 1979
- A study of proteases and protease-inhibitor complexes in biological fluidsThe Journal of Experimental Medicine, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970